Terminal half‐life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database-Reference-Cited by-同舟云学术

Terminal half‐life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database

Published:2021-06-18 Issue:8 Volume:19 Page:1896-1906
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J. Thromb. Haemost.

Author:

Versloot Olav¹^ORCID,Iserman Emma²,Chelle Pierre³^ORCID,Germini Federico²⁴^ORCID,Edginton Andrea N.³^ORCID,Schutgens Roger E. G.¹^ORCID,Iorio Alfonso²⁴⁵^ORCID,Fischer Kathelijn¹^ORCID,

Affiliation:

1. Van Creveldkliniek University Medical Centre Utrecht Utrecht The Netherlands

2. Department of Health Research Methods, Evidence, and Impact McMaster University Hamilton ON Canada

3. School of Pharmacy University of Waterloo Waterloo ON Canada

4. Department of Medicine McMaster University Hamilton ON Canada

5. McMaster‐Bayer Endowed Research Chair in Clinical Epidemiology of Congenital bleeding DisordersDepartment of MedicineMcMaster Hamilton ON Canada

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15395

Reference55 articles.

1. WFH Guidelines for the Management of Hemophilia, 3rd edition

2. EMA.Product characteristics Kogenate ‐ Annex I.2010.

3. EMA.Product characteristics Advate ‐ Annex I.2013.

4. EMA.Product characteristics Kovaltry ‐ Annex I.2016.

5. Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perioperative Management of Hemophilia Patients;Current Anesthesiology Reports;2024-06-14

2. Classification of recombinant factor VIII products and implications for clinical practice: A systematic literature review;Haemophilia;2024-03-29

3. Cases of less‐than‐expected FVIII activity in previously treated patients during post‐marketing surveillance of N8‐GP;Haemophilia;2023-09-20

4. The road to implementation of pharmacokinetic-guided dosing of factor replacement therapy in hemophilia and allied bleeding disorders. Identifying knowledge gaps by mapping barriers and facilitators;Blood Reviews;2023-09

5. MUW researcher of the month;Wiener klinische Wochenschrift;2023-06